Healthleap has raised $38 million across seed and Series A financings to expand AI software that screens hospital records for conditions that may otherwise be missed. The financing includes an $8 million seed round backed by Sequoia Capital and First Round Capital and a $30 million Series A led by Hummingbird Ventures.
The company began with a focus on clinical nutrition and now targets broader risks, including conditions that can be overlooked during a hospital stay. Its software reads patient records and surfaces cases that merit a clinician’s attention. The system is designed to prioritize review, not independently diagnose patients or replace medical judgment.
Founded by siblings Jemima and Josiah Meyer, Healthleap says its platform is used by major healthcare systems. Adoption in this sector requires more than a high-performing model: products have to integrate with electronic health records, avoid alert fatigue and demonstrate that their recommendations improve care.
The company plans to use the funding to expand into more conditions and add product and commercial staff. The crucial commercial question is whether hospitals see better patient outcomes or operating efficiency without increasing clinicians’ administrative workload. A screening model only creates value when it produces action that care teams can realistically take.